Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports-Reference-Cited by-同舟云学术

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports

Published:2019-01-22 Issue:1 Volume:5 Page:
ISSN:2055-8260
Container-title:Clinical Diabetes and Endocrinology
language:en
Short-container-title:Clin Diabetes Endocrinol

Author:

Tan Meng H.^ORCID,Iyengar Ravi,Mizokami-Stout Kara,Yentz Sarah,MacEachern Mark P.,Shen Li Yan,Redman Bruce,Gianchandani Roma

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40842-018-0073-4.pdf

Reference209 articles.

1. FDA. Pembrolizumab (KEYTRUDA) Prescribing Information 2017 [Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125514s031lbl.pdf Accessed 17 May 2018.

2. FDA. Nivolumab (OPDIVO) Prescribing Information 2017 [Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125554s035s036s037s038s039lbl.pdf Accessed 17 May 2018.

3. FDA. Ipilimumab (YERVOY) Prescribing Information 2017 [Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125377s091lbl.pdf Accessed 17 May 2018.

4. FDA. Atezolizumab (TECENTRIQ) Prescribing Information. 2018 [cited 2018; Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761034s005lbl.pdf Accessed 17 May 2018.

5. FDA. Durvalumab (IMFINZI) Prescribing Information. 2018 [cited 2018; Available fro Accessed 17 May 2018.

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of hormonal changes in hypophysitis by immune checkpoint inhibitor;The Korean Journal of Internal Medicine;2024-09-01

2. Endocrine toxicity of cancer immunotherapy;International Journal of Molecular and Immuno Oncology;2024-08-31

3. Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy;Reviews in Endocrine and Metabolic Disorders;2024-08-22

4. Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update;Journal for ImmunoTherapy of Cancer;2024-07

5. Immune checkpoint inhibitors-related endocrinopathies exhibit increased severity in breast cancer patients: a real-world study;Endocrine;2024-06-29